Several Amarillo residents could make a big different in saving people during the early stages of COVID-19.
Since August, the Pharmatex research facility has been asking people who have been COVID-19 positive for three days to participate in their double-blind Regeneron antibody trial.
These patients either receive a full, limited or placebo of an antibody designed to diminish severe symptoms…
To access content, please login or purchase a subscription.